These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 17600873)

  • 1. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer.
    Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M
    J BUON; 2007; 12(2):203-8. PubMed ID: 17600873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: a phase II study.
    Giralt J; Tabernero J; Navalpotro B; Capdevila J; Espin E; Casado E; Mañes A; Landolfi S; Sanchez-Garcia JL; de Torres I; Armengol M
    Radiother Oncol; 2008 Dec; 89(3):263-9. PubMed ID: 18768230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up.
    Fernández-Martos C; Aparicio J; Bosch C; Torregrosa M; Campos JM; Garcera S; Vicent JM; Maestu I; Climent MA; Mengual JL; Tormo A; Hernandez A; Estevan R; Richart JM; Viciano V; Uribe N; Campos J; Puchades R; Arlandis F; Almenar D
    J Clin Oncol; 2004 Aug; 22(15):3016-22. PubMed ID: 15210740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
    Pfeiffer P
    Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.
    Wang LW; Yang SH; Lin JK; Lin TC; Chan WK; Chen WS; Wang HS; Jiang JK; Lee RC; Li AF; Chao Y; Chi KH; Yen SH
    J Surg Oncol; 2005 Mar; 89(4):256-63; discussion 263-4. PubMed ID: 15726610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW; Jensen HA; Pfeiffer P
    Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
    Kundel Y; Brenner B; Symon Z; Oberman B; Sadezki S; Koller M; Catane R; Pfeffer R
    Anticancer Res; 2007; 27(4C):2877-80. PubMed ID: 17695464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
    J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
    Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
    Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer.
    Hsieh CH; Chen YJ; Chang KH; Hsu HH; Liu CK; Hung SK; Chen HW; Lai YL; Hsu TC
    Anticancer Res; 2006; 26(5B):3709-15. PubMed ID: 17094389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin-C/5-fluorouracil/leucovorin and hyperfractionated radiation therapy for rectal carcinoma: a phase II study with long-term follow-up.
    Nabhan C; Ragam A; Samuels B; Milton DT; Prasad L; Hooberman A; Hartsell W; Anthony A; Weisman R; Bitran JD
    Clin Colorectal Cancer; 2007 Mar; 6(6):436-41. PubMed ID: 17531107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
    Byström P; Frödin JE; Berglund A; Wilking N; Glimelius B
    Radiother Oncol; 2004 Feb; 70(2):171-5. PubMed ID: 15028404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.